financetom
Business
financetom
/
Business
/
Form 8.3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3
Mar 16, 2026 4:08 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

NATIXIS SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Just Group plc ( JTGPF )

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13 March 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

23 615 241

2,27

-

0,00

(2) Cash-settled derivatives:

 

-

0,00

23 615 241

2,27

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

23 615 241

2,27

23 615 241

2,27

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

7 077

GBX 216.50

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e,g, CFD

Nature of dealing

e,g, opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

Structured product

Increasing a short position

7 077

GBX 216.50

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e,g, call option

Writing, purchasing, selling, varying etc,

Number of securities to which option relates

Exercise price per unit

Type

e,g, American, European etc,

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e,g, call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e,g, subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4, OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included, If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(c) Attachments

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

23 615 241

2,27

-

0,00

(2) Cash-settled derivatives:

 

-

0,00

23 615 241

2,27

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

23 615 241

2,27

23 615 241

2,27

0

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

23 615 241

2,27

-

0,00

(2) Cash-settled derivatives:

 

-

0,00

23 615 241

2,27

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

23 615 241

2,27

23 615 241

2,27

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service,

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129,

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit,

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

Source: NATIXIS

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UiPath Collaborates With Snowflake to Link AI Insights With Business Automation
UiPath Collaborates With Snowflake to Link AI Insights With Business Automation
Sep 30, 2025
09:21 AM EDT, 09/30/2025 (MT Newswires) -- UiPath ( PATH ) said Tuesday it will combine its Maestro platform with Snowflake's (SNOW) Cortex AI to coordinate artificial intelligence-powered agents that analyze both structured and unstructured data in Snowflake. The data agents will use Cortex Analyst and Cortex Search to generate insights, which can then trigger automation workflows through UiPath (...
OPEC+ to consider bigger increase to oil output, sources say
OPEC+ to consider bigger increase to oil output, sources say
Sep 30, 2025
LONDON (Reuters) -OPEC+ is likely to consider a larger oil production increase of 411,000 barrels per day for November at its meeting next Sunday as rising oil prices encourage the group to try to regain more market share, said two sources familiar with the talks. OPEC+ has reversed its earlier strategy of output cuts and has already raised quotas by...
Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria
Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria
Sep 30, 2025
09:21 AM EDT, 09/30/2025 (MT Newswires) -- Disc Medicine ( IRON ) said Tuesday it has submitted a new drug application with the US Food and Drug Administration for bitopertin to treat patients 12 years and older with erythropoietic protoporphyria, including X-linked protoporphyria. The biopharmaceutical company filed the NDA under the FDA's Accelerated Approval Program and requested a priority review,...
Cardinal expands drug distribution network with new Indianapolis facility
Cardinal expands drug distribution network with new Indianapolis facility
Sep 30, 2025
Sept 30 (Reuters) - Cardinal Health ( CAH ) said on Tuesday it will start a new facility in Indianapolis, Indiana, which is expected to create more than 100 new jobs and expand the company's drug distribution network. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved